Automating Physical Therapy Biologics Prior Auth
Klivira streamlines the complex process of physical therapy biologics prior auth, ensuring seamless care coordination for patients undergoing specialized treatments.
For revenue cycle directors and prior authorization coordinators in physical therapy, managing biologics prior authorization presents unique challenges. While biologics are often prescribed by other specialties, PT clinics frequently treat patients on these high-cost medications for conditions like rheumatoid arthritis or psoriatic arthritis. Efficiently navigating these authorizations is critical for patient access to necessary rehabilitation and for maintaining revenue integrity.
The Intersection of Physical Therapy and Biologics Prior Auth
Patients receiving physical therapy for chronic inflammatory conditions, post-surgical rehabilitation, or complex musculoskeletal issues are often concurrently managed with specialty biologics. These therapies, including TNF inhibitors or IL-17/23 inhibitors, require stringent prior authorization due to their high cost and specific medical necessity criteria. PT practices must ensure alignment with the overarching treatment plan, including the PA status of these critical medications, to optimize patient outcomes and prevent care delays.
Common PA Triggers for Patients on Biologics in PT
- High-cost specialty biologic medications for underlying conditions (e.g., rheumatoid arthritis, psoriatic arthritis) impacting rehabilitation.
- Visit-cap exceptions for chronic conditions requiring extended physical therapy, often in conjunction with biologic treatment.
- Post-surgical authorizations for patients whose recovery is influenced by inflammatory conditions managed with biologics.
- Authorization for advanced modalities or extended courses of therapy where biologics are part of the broader care plan.
- Periodic re-authorization requirements for both the biologic and ongoing physical therapy.
Klivira's Automated Workflow for Biologics PA
Klivira's platform automates the intricate steps of biologics prior authorization, supporting coordinated care across specialties. Our system performs indication classification from EMR diagnoses, automates step therapy logic by pulling prior-line therapy history, and routes based on per-payer biosimilar substitution policies. It also streamlines screening documentation (e.g., TB, hepatitis status) from FHIR data and manages periodic re-authorization cycles with continuous disease-activity documentation, critical for patients in physical therapy.
EMR and Payer Touchpoints for Coordinated Care
Klivira integrates directly with major EMR systems via SMART on FHIR, enabling bidirectional data exchange for patient demographics, diagnoses, and clinical notes relevant to both physical therapy and biologic prescriptions. Our platform connects to payer portals and utilizes industry standards like X12 278 and NCPDP SCRIPT for ePA submissions, providing a unified view of PA status. This ensures that physical therapy teams have visibility into the authorization status of biologics, facilitating better care coordination and reducing administrative burden.
Clinical Guideline Alignment and Compliance Considerations
Our automation logic is informed by established clinical guidelines from bodies like the American College of Rheumatology (ACR) for inflammatory arthropathies, ensuring that authorization requests align with evidence-based criteria. While Klivira automates the submission process, practices must consult with their compliance teams regarding HIPAA and PHI handling, especially when coordinating care involving specialty medications across multiple providers.
Frequently asked questions
How does Klivira handle prior authorization for physical therapy visit-cap exceptions when a patient is on biologics?
Klivira's platform can be configured to manage visit-cap exception requests by leveraging EMR data to demonstrate medical necessity, especially for chronic conditions often treated with biologics. Our system helps compile the necessary clinical documentation to support extended therapy, aligning with payer policies and the patient's overall treatment plan.
Can Klivira integrate with our EMR to pull patient data relevant to biologics prior auth for PT patients?
Yes, Klivira integrates with EMRs using SMART on FHIR to securely pull relevant patient data, including diagnoses, medication history, and clinical notes. This data is crucial for automating the submission of prior authorizations, including supporting documentation for biologics and physical therapy services.
What role does Klivira play in managing periodic re-authorizations for biologics for our PT patient cohort?
Klivira automates the tracking and initiation of periodic re-authorizations for biologics, which often occur on 6 or 12-month cycles. Our system prompts for updated clinical documentation, such as disease activity scores or functional improvements from physical therapy, to support ongoing medical necessity and ensure continuous patient access to treatment.
How does Klivira ensure compliance with payer-specific step therapy requirements for biologics?
Klivira's platform incorporates payer-specific step therapy logic, identifying prior-line therapy history from EMR data. This ensures that biologic prior authorization requests meet the prerequisite treatment requirements, such as trial of conventional DMARDs or other therapies, reducing the likelihood of denials due to non-compliance with payer protocols.
Is Klivira's platform capable of distinguishing between medical and pharmacy benefit for biologics?
Yes, Klivira's system is designed to route prior authorization requests appropriately based on whether the biologic is covered under the medical or pharmacy benefit. This distinction is critical as the same agent may have different benefit-side coverage depending on its administration mode, ensuring the correct channels are utilized for submission.
Related coverage
Other physical-therapy prior auth workflows
- Achieving Physical Therapy CMS-0057-F Compliance
- Optimizing Physical Therapy Denial Management with Klivira
- Automating Physical Therapy GLP-1 Prior Auth for Integrated Care
- Optimizing Physical Therapy Payer Portal Automation
- Optimizing Physical Therapy Prior Authorization Automation
- Automating Physical Therapy Prior Auth with SMART on FHIR Integration
- Automating Physical Therapy Specialty Drug Prior Auth for Efficient Patient Care
Ready to automate this workflow for this specialty?
See how Klivira automates prior authorizations for your team.
Request a demo